Nucleosides

2'-Modified Nucleosides
(288/288)
3'-Modified Nucleosides
(157/157)
5'-Modified Nucleosides
(236/236)
Anhydro-Nucleosides
(13/13)
Arabinonucleosides
(34/34)
Base Protected Nucleosides
(224/224)
Halogen Nucleosides
(134/134)
L-Nucleosides
(18/18)
Other Nucleosides
(77/77)
Other Protected Nucleosides
(23/23)
Ribonucleosides
(11/11)
Backbone
Modification
Base Type
Filtered by
Clear All

N6-Benzoyl-9-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)adenine

Description: N6-Benzoyl-9-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)adenine is a potent antiviral drug specifically used in the treatment of various viral infections. It exhibits remarkable activity against various DNA viruses, including herpes simplex virus and varicella-zoster virus. This product acts by inhibiting viral DNA synthesis and effectively reducing the viral load, thus aiding in the management of viral diseases.
CAT: BRP-02000
CAS: 226415-08-3
MF: C38H34FN5O6
MF: 675.71
Purity: ≥95%
Appearance: White to Off-white Crystalline Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.35±0.1 g/cm3
Boiling Point: 869.8±75.0°C at 760 mmHg
InChIKey: DDOOVEXTSRBCMU-MHHBZGPPSA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)NC(=O)C7=CC=CC=C7)F)O
IUPAC Name: N-[9-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]purin-6-yl]benzamide
InChI: InChI=1S/C38H34FN5O6/c1-47-28-17-13-26(14-18-28)38(25-11-7-4-8-12-25,27-15-19-29(48-2)20-16-27)49-21-30-33(45)31(39)37(50-30)44-23-42-32-34(40-22-41-35(32)44)43-36(46)24-9-5-3-6-10-24/h3-20,22-23,30-31,33,37,45H,21H2,1-2H3,(H,40,41,43,46)/t30-,31+,33-,37-/m1/s1
Synonyms: 5'-O-DMT-N6-Bz-2'-F-ara-2'-dA; 5-O-(4,4'-dimethoxytrityl)-N6-benzoyl-2'-fluoro-β-D-arabinofuranosyl-2'-deoxyadenine; N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-fluoro-2'-deoxy-arabinoadenosine; 9-[2-Deoxy-5-O-(4,4'-dimethoxytrityl)-2-fluoro-beta-D-arabinofuranosyl]-N6-benzoyladenine; N-(9-((2R,3S,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide; 5'-O-DMT-N6-Bz-2'-ara-F-2'-dA; N6-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-arabinoadenosine; 9-{5-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-2-deoxy-2-fluoro-β-D-arabinofuranosyl}-6-{[hydroxy(phenyl)methylene]amino}-9H-purine

5'-O-DMT-2'-Fluoro-N4-phenoxyacetyl-2'-Deoxycytidine

Description: 5'-O-DMT-2'-Fluoro-N4-phenoxyacetyl-2'-Deoxycytidine, a synthetic nucleoside analog employed in the battle against cancer, has been observed to specifically suppress DNA synthesis and impede cancer cells during the S-phase of the cell cycle.
CAT: BRP-02001
CAS: 1569628-14-3
MF: C38H36FN3O8
MF: 681.72
Purity: ≥97% by HPLC
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.30±0.1 g/cm3
InChIKey: WJSJHBILJKEBJS-MBWVZDRISA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=CC(=NC5=O)NC(=O)COC6=CC=CC=C6)F)O
IUPAC Name: N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]-2-phenoxyacetamide
InChI: InChI=1S/C38H36FN3O8/c1-46-28-17-13-26(14-18-28)38(25-9-5-3-6-10-25,27-15-19-29(47-2)20-16-27)49-23-31-35(44)34(39)36(50-31)42-22-21-32(41-37(42)45)40-33(43)24-48-30-11-7-4-8-12-30/h3-22,31,34-36,44H,23-24H2,1-2H3,(H,40,41,43,45)/t31-,34-,35-,36-/m1/s1
Synonyms: 5'-O-DMT-N4-PAc-2'-F-dC; 5'-O-DMT-2'-F-N4-PAc-dC; Cytidine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-N-(2-phenoxyacetyl)-; 2'-Deoxy-5'-O-DMT-2'-fluoro-N4-phenoxyacetylcytidine; 5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-2'-deoxy-2'-fluoro-N-(phenoxyacetyl)cytidine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-N-(2-phenoxyacetyl)cytidine

N2-iso-Butyroyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2'-fluoro-arabinoguanosine

Description: N2-iso-Butyroyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2'-fluoro-arabinoguanosine, a groundbreaking compound prominently employed within the biomedical field, showcases tremendous promise in combatting an array of diseases, notably viral infections and cancers. With its potent characteristics, this extraordinary product serves as a fundamental component in synthesizing nucleoside analogs, thus propelling the advancement of innovative therapeutic initiatives
CAT: BRP-02002
CAS: 2409054-22-2
MF: C35H36FN5O7
MF: 657.69
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.38±0.1 g/cm3
InChIKey: QQQXVSXVBFQISZ-IYZGCQLGSA-N
CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)F
IUPAC Name: N-[9-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
InChI: InChI=1S/C35H36FN5O7/c1-20(2)31(43)39-34-38-30-28(32(44)40-34)37-19-41(30)33-27(36)29(42)26(48-33)18-47-35(21-8-6-5-7-9-21,22-10-14-24(45-3)15-11-22)23-12-16-25(46-4)17-13-23/h5-17,19-20,26-27,29,33,42H,18H2,1-4H3,(H2,38,39,40,43,44)/t26-,27+,29-,33-/m1/s1
Synonyms: 5'-O-DMT-N2-ibu-2'-F-ara-2'-dG; 9-[2-Deoxy-5-O-(4,4'-dimethoxytrityl)-2-fluoro-beta-D-arabinofuranosyl]-N2-isobutyrylguanine; N-(9-((2S,3R,4S,5S)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide; 5-O-(4,4'-Dimethoxytrityl)-N2-isobutyryl-2'-fluoro-β-D-arabinofuranosyl-2'-deoxyguanosine; 2'-Deoxy-5'-O-DMT-2'-ara-fluoro-N2-isobutyrylguanosine; 5'-O-DMT-2'-ara-fluoro-N2-isobutyryl-2'-deoxyguanosine; 9-{5-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-2-deoxy-2-fluoro-β-D-arabinofuranosyl}-2-(isobutyrylamino)-1,9-dihydro-6H-purin-6-one; N2-iBu-DMT-2'-F-dG; 5'-O-DMT-N2-ibu-2'-ara-F-2'-dG

5'-O-DMT-N4-Ac-2'-ara-F-2'-dC

Description: 5'-O-DMT-N4-Ac-2'-ara-F-2'-dC, an antiviral drug designed to combat HCV infections, is a possible game-changer in the world of virology. Its RNA-replication-inhibiting abilities have been shown to be incredibly strong in test conditions against HCV genotypes 1a and 1b. The compound's activity makes it a viable option for antiviral therapy, signaling hope for those affected by HCV.
CAT: BRP-02003
CAS: 3002027-47-3
MF: C32H32FN3O7
MF: 589.62
Purity: ≥97% by HPLC
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.31±0.1 g/cm3
InChIKey: JIFNUYITABZZQS-RRFVUZEHSA-N
CanonicalSMILES: CC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O)F
IUPAC Name: N-[1-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
InChI: InChI=1S/C32H32FN3O7/c1-20(37)34-27-17-18-36(31(39)35-27)30-28(33)29(38)26(43-30)19-42-32(21-7-5-4-6-8-21,22-9-13-24(40-2)14-10-22)23-11-15-25(41-3)16-12-23/h4-18,26,28-30,38H,19H2,1-3H3,(H,34,35,37,39)/t26-,28+,29-,30-/m1/s1
Synonyms: 5'-O-DMT-N4-Ac-2'-F-ara-2'-dC; 5-O-(4,4'-dimethoxytrityl)-N4-acetyl-2'-fluoro-β-D-arabinofuranosyl-2'-deoxycytidine; N-(1-((2R,3S,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide; 5'-O-DMT-2'-FANA-2'-deoxy-N4-acetyl-cytidine; WV-NU-285

5'-O-(4,4'-Dimethoxytrityl)-2'-deoxy-2'-fluoro-b-D-arabinouridine

Description: 5'-O-(4,4'-Dimethoxytrityl)-2'-deoxy-2'-fluoro-b-D-arabinouridine, a potent nucleoside analog effective in prostate and bladder cancer, has an inhibitory effect on DNA synthesis and selective apoptosis of cancer cells. Beyond this, the compound displays promising antiviral activity against RNA viruses. Perhaps, its unique chemical composition lends to its versatile application and efficacy in medical research.
CAT: BRP-02004
CAS: 144822-63-9
MF: C30H29FN2O7
MF: 548.56
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.38±0.1 g/cm3
InChIKey: CSSFZSSZXOCCJB-KCPYNUOSSA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=CC(=O)NC5=O)F)O
IUPAC Name: 1-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C30H29FN2O7/c1-37-22-12-8-20(9-13-22)30(19-6-4-3-5-7-19,21-10-14-23(38-2)15-11-21)39-18-24-27(35)26(31)28(40-24)33-17-16-25(34)32-29(33)36/h3-17,24,26-28,35H,18H2,1-2H3,(H,32,34,36)/t24-,26+,27-,28-/m1/s1
Synonyms: 5-O-(4,4'-dimethoxytrityl)-2'-fluoro-β-D-arabinofuranosyl-2'-deoxyuridine; 1-(2'-Deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)uracil; 1-(2'-Deoxy-5'-O-dimethoxytrityl-2'-fluoro-b-D-arabinofuranosyl)uracil; 5'-O-DMT-2'-F-ara-2'-dU; 1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-2-fluoro-β-D-arabinofuranosyl]-2,4(1H,3H)-pyrimidinedione; WV-NU-284

N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2'-fluoro-b-D-arabinocytidine

Description: N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2'-fluoro-b-D-arabinocytidine is a paramount compound with antiviral and antitumor properties. This extraordinary product is used to study viral infections, specifically those perpetuated by DNA viruses and RNA viruses.
CAT: BRP-02005
CAS: 154771-33-2
MF: C37H34FN3O7
MF: 651.68
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C
Density: 1.30±0.1 g/cm3
InChIKey: RAIBEZUVTIPFOJ-SHERYBNQSA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=CC(=NC5=O)NC(=O)C6=CC=CC=C6)F)O
IUPAC Name: N-[1-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
InChI: InChI=1S/C37H34FN3O7/c1-45-28-17-13-26(14-18-28)37(25-11-7-4-8-12-25,27-15-19-29(46-2)20-16-27)47-23-30-33(42)32(38)35(48-30)41-22-21-31(40-36(41)44)39-34(43)24-9-5-3-6-10-24/h3-22,30,32-33,35,42H,23H2,1-2H3,(H,39,40,43,44)/t30-,32+,33-,35-/m1/s1
Synonyms: 5-O-(4,4'-dimethoxytrityl)-N4-benzoyl-2'-fluoro-β-D-arabinofuranosyl-2'-deoxycytidine; 5'-O-DMT-N4-Bz-2'-F-ara-2'-dC; DMT-2'-F-Bz-dC; 1-[2-Deoxy-5-O-(4,4'-dimethoxytrityl)-2-fluoro-beta-D-arabinofuranosyl]-N4-benzoylcytosine; 4-Benzamido-1-{5-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2-deoxy-2-fluoro-beta-D-arabinofuranosyl}pyrimidin-2(1H)-one; 5-O-DMT-N4-Bz-2-ara-F-2-dC; N-[1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-2-fluoro-beta-D-arabinofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]benzamide

5-Bromo-2′-deoxy-2′-fluorouridine

Description: 5-Bromo-2'-deoxy-2'-fluorouridine is an analog of Uridine and used as a reagent in the synthesis of β-D-arabinofuranosyl and deoxyfluoro-β-D-ribofuranosyl pyrimidine nucleoside analogs which exhibit antituberculosis activity against Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro.
CAT: BRP-02006
CAS: 55612-18-5
MF: C29H21NO4
MF: 447.5
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
Density: 1.98±0.1 g/cm3 (Predicted)
InChIKey: WFOXFPXBLFRFHB-CDRSNLLMSA-N
CanonicalSMILES: CCOC(=O)C1=C2C=C(C=CN2C(=C1)C(=O)C3=CC4=CC=CC=C4C=C3)C(=O)C5=CC=CC=C5
IUPAC Name: 5-bromo-1-[(3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H10BrFN2O5/c10-3-1-13(9(17)12-7(3)16)8-5(11)6(15)4(2-14)18-8/h1,4-6,8,14-15H,2H2,(H,12,16,17)/t4-,5-,6-,8?/m1/s1
Synonyms: 55612-18-5;5-bromo-1-[(3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione;5-Bromo-1-(2-fluoro-2-deoxyribofuranosyl)uracil;5-Bfdu;5-Bromo-1-(2-fluoro-2-deoxyuridine);5-Bromo-1-(2-fluoro-2-deoxy-beta-D-ribofuranosyl)uracil;DTXSID80970954;Uridine, 5-bromo-2'-deoxy-2'-fluoro-;5-(76Br)bromo-2'-fluoro-2'-deoxyuridine;5-Bromo-1-(2-deoxy-2-fluoropentofuranosyl)-4-hydroxypyrimidin-2(1H)-one;5-bromo-1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione;

2'-Deoxy-2'-fluorocytidine hydrate

Description: 2'-Deoxy-2'-fluorocytidine hydrate is a nucleoside analog with potent anti-cancer activity due to its ability to disrupt DNA synthesis, resulting in cancer cell death. This small molecule has demonstrated efficacy against a range of malignancies, including colon, lung, and pancreatic cancers. Moreover, ongoing research is exploring its use in combating challenging viral infections, such as hepatitis B and HIV.
CAT: BRP-02014
CAS: 1820580-34-4
MF: C9H14FN3O5
MF: 263.22
Purity: 95%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, protect from light
InChIKey: KUYKYENKWWNPHG-IAIGYFSYSA-N
CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)F.O
IUPAC Name: 4-amino-1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrate
InChI: InChI=1S/C9H12FN3O4.H2O/c10-6-7(15)4(3-14)17-8(6)13-2-1-5(11)12-9(13)16;/h1-2,4,6-8,14-15H,3H2,(H2,11,12,16);1H2/t4-,6-,7-,8-;/m1./s1
Synonyms: 2-Deoxy-2-fluorocytidine hydrate; 4-Amino-1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one hydrate; 2'-Fluoro Cytidine hydrate; 2'-Fluoro-2'-deoxy-β-D-ribofuranosylcytosine hydrate; 2'-Fluoro-2'-deoxycytidine hydrate; 2'-F-dC hydrate
Related CAS: 10212-20-1 (anhydrous)

5'-O-DMT-2'-fluoro-2'-deoxyinosine

Description: 5'-O-DMT-2'-fluoro-2'-deoxyinosine is a chemically modified nucleoside utilized in oligonucleotide synthesis to enhance stability and specificity. The 2'-fluoro modification increases resistance to enzymatic degradation, while inosine's ability to base-pair with adenine, cytosine, and uracil provides flexibility in nucleic acid interactions. This nucleoside is integral in developing oligonucleotides for therapeutic applications, such as antisense oligonucleotides and siRNAs, and supports research into nucleic acid structure, function, and hybridization properties.
CAT: BRP-02015
CAS: 1951424-83-1
MF: C31H29FN4O6
MF: 572.58
Purity: ≥98% by HPLC
Appearance: White to off-white solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
Density: 1.39±0.1 g/cm3
Boiling Point: 807.8±75.0 °C at 760 mmHg
InChIKey: QDCBEGXXNGZTON-QNYAKKFESA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=NC6=C5N=CNC6=O)F)O
IUPAC Name: 9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C31H29FN4O6/c1-39-22-12-8-20(9-13-22)31(19-6-4-3-5-7-19,21-10-14-23(40-2)15-11-21)41-16-24-27(37)25(32)30(42-24)36-18-35-26-28(36)33-17-34-29(26)38/h3-15,17-18,24-25,27,30,37H,16H2,1-2H3,(H,33,34,38)/t24-,25-,27-,30-/m1/s1
Synonyms: DMT-2'-F-dI; 5'-O-(4,4'-Dimethoxytrityl)-2'-fluoro-2'-deoxyinosine; 9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-3,9-dihydro-6H-purin-6-one; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroinosine

2',2'-Difluoro-2'-deoxyuridine 3',5'-Dibenzoate

Description: 2',2'-Difluoro-2'-deoxyuridine 3',5'-dibenzoate is a modified nucleoside derivative where the 2'-hydroxyl group of deoxyuridine is replaced by difluoromethylene (-CF2-) and the 3' and 5' positions of the sugar moiety are esterified with dibenzoate groups. This modification enhances the stability and alters the chemical properties of the nucleoside, making it useful in nucleic acid chemistry for applications such as nucleotide analog synthesis and structural studies.
CAT: BRP-02023
CAS: 143157-27-1
MF: C23H18F2N2O7
MF: 472.39
Purity: ≥98%
Appearance: White Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
Density: 1.49±0.1 g/cm3
InChIKey: DBSVRWFIIMWGLT-HGHGUNKESA-N
Solubility: Soluble in Dichloromethane, Methanol
CanonicalSMILES: C1=CC=C(C=C1)C(=O)OCC2C(C(C(O2)N3C=CC(=O)NC3=O)(F)F)OC(=O)C4=CC=CC=C4
IUPAC Name: [(2R,3R,5R)-3-benzoyloxy-5-(2,4-dioxopyrimidin-1-yl)-4,4-difluorooxolan-2-yl]methyl benzoate
InChI: InChI=1S/C23H18F2N2O7/c24-23(25)18(34-20(30)15-9-5-2-6-10-15)16(13-32-19(29)14-7-3-1-4-8-14)33-21(23)27-12-11-17(28)26-22(27)31/h1-12,16,18,21H,13H2,(H,26,28,31)/t16-,18-,21-/m1/s1
Synonyms: 3',5'-Dibenzoate-2',2'-Difluoro-2'-deoxyuridine; 3,5-Dibenzoate-2,2-difluorouridine; 3',5'-Di-O-benzoyl-2'-deoxy-2',2'-difluorouridine; Uridine, 2'-deoxy-2',2'-difluoro-, 3',5'-dibenzoate; ((2R,3R,5R)-3-(benzoyloxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4,4-difluorotetrahydrofuran-2-yl)methyl benzoate

2'-Deoxy-2'-fluoro-beta-D-arabinocytidine hydrochloride

Description: It is a metabolite of Fiacitabine (FIAC) and a related substance of Azvudine. It is used as an anticancer agent.
CAT: BRP-02025
CAS: 25183-22-6
MF: C9H12FN3O4.HCl
MF: 281.67
Purity: ≥95%
Appearance: White solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, under inert atmosphere
Melting Point: 241-242°C (dec.)
InChIKey: AOHUNXMLBSSCKF-NKCNMFRMSA-N
CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)F.Cl
IUPAC Name: 4-amino-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride
InChI: InChI=1S/C9H12FN3O4.ClH/c10-6-7(15)4(3-14)17-8(6)13-2-1-5(11)12-9(13)16;/h1-2,4,6-8,14-15H,3H2,(H2,11,12,16);1H/t4-,6+,7-,8-;/m1./s1
Synonyms: FAC hydrochloride; 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)cytosine hydrochloride; 2'-Deoxy-2'-fluoro-β-D-arabinocytidine hydrochloride; 1-(2'-Deoxy-2'-fluoro-b-D-arabinofuranosyl)cytosine HCl; 4-Amino-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-2(1H)-pyrimidinone hydrochloride; 4-Amino-1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one hydrochloride
Related CAS: 56632-83-8 (free base)

1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)uracil

Description: 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)uracil, a pivotal compound extensively employed in the realm of biomedical research, boasts an impressive array of antiviral properties. It showcases exceptional efficacy in countering an extensive spectrum of viral infections, encompassing the notorious herpes simplex virus 1 and 2.
CAT: BRP-02026
CAS: 69123-94-0
MF: C9H11FN2O5
MF: 246.19
Purity: ≥95%
Appearance: White to off-white solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C
Density: 1.63 g/cm3
Melting Point: 162°C
Application: Growth Inhibitors
InChIKey: UIYWFOZZIZEEKJ-PXBUCIJWSA-N
Solubility: Soluble in Chloroform, Methanol
CanonicalSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F
IUPAC Name: 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6+,7-,8-/m1/s1
Synonyms: 2'-Deoxy-2'-fluoro-beta-D-arabinouridine; 2'-deoxy-2'-fluoro-arabino-uridine; 2'-FANA-Ur; 2'-Deoxy-2'-fluoro-ara-uridine; 1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 2'-Fluoro-arabinofuranosyl-2'-deoxy-uridine; 1-(2-Deoxy-2-fluoro-b-D-arabinofuranosyl)uracil

2'-Deoxy-2'-fluoro-beta-D-arabinocytidine

Description: It is a metabolite of FIAC and an impurity of Azvudine. It is also an anticancer agent.
CAT: BRP-02029
CAS: 56632-83-8
MF: C9H12FN3O4
MF: 245.21
Purity: ≥95%
Appearance: White foam powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, under inert atmosphere
Density: 1.82±0.1 g/cm3 (Predicted)
Melting Point: 136-138°C
Boiling Point: 500.1±60.0 °C at 760 mmHg
InChIKey: NVZFZMCNALTPBY-PXBUCIJWSA-N
CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)F
IUPAC Name: 4-amino-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChI: InChI=1S/C9H12FN3O4/c10-6-7(15)4(3-14)17-8(6)13-2-1-5(11)12-9(13)16/h1-2,4,6-8,14-15H,3H2,(H2,11,12,16)/t4-,6+,7-,8-/m1/s1
Synonyms: 2'-Fluoro-2'-deoxy-arabinofuranosyl-cytidine; 2'-FANA-Cr; 4-Amino-1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one; 4-Amino-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-2(1H)-pyrimidinone; NUK-8; 2'-F-araC; 2'-deoxy-2'-fluoro-arabino-cytidine
Related CAS: 25183-22-6 (hydrochloride)

Fialuridine

Description: Fialuridine (FIAU) is a thymidine-based nucleoside analog with antiviral activity. Fialuridine and its metabolites blocks DNA synthesis in human cytomegalovirus and hepatitis B, as well as herpes simplex.
CAT: BRP-02030
CAS: 69123-98-4
MF: C9H10FIN2O5
MF: 372.09
Purity: ≥95%
Appearance: White to off-white solid or powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C
Density: 2.18±0.1 g/cm3 (Predicted)
Melting Point: 216-217 °C
Application: Antiviral Agents
InChIKey: IPVFGAYTKQKGBM-BYPJNBLXSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)
CanonicalSMILES: C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)I
IUPAC Name: 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione
InChI: InChI=1S/C9H10FIN2O5/c10-5-6(15)4(2-14)18-8(5)13-1-3(11)7(16)12-9(13)17/h1,4-6,8,14-15H,2H2,(H,12,16,17)/t4-,5+,6-,8-/m1/s1
Synonyms: 5-Iodo-2'-deoxy-2'-fluoro-beta-D-arabinouridine; FIAU; Fluoroiodoarauracil; 5-Iodo-2'-Fluoroarauracil; NSC 678514; 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodo-2,4(1H,3H)-pyrimidinedione; 1-(2'-Deoxy-2'-fluoro-β-D-arabinofuranosyl)-5-iodouracil

2'-Deoxy-2'-fluoro-5-fluoro-arabinouridine

Description: 2'-Deoxy-2'-fluoro-5-fluoro-arabinouridine is an exceptional antiviral compound, exhibiting remarkable potential in the research of biomedicine for tackling viral afflictions. Its robustness lies in its ability to suppress viral replication through the selective inhibition of viral polymerase activity, impeding viral RNA synthesis.
CAT: BRP-02031
CAS: 69123-95-1
MF: C9H10F2N2O5
MF: 264.18
Purity: ≥95%
Appearance: White solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C
Density: 1.69±0.1 g/cm3
Melting Point: 168-170°C
Application: Enzyme Inhibitors
InChIKey: QURNODSOJKSTBM-BYPJNBLXSA-N
Solubility: Soluble in Chloroform, Methanol
CanonicalSMILES: C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)F
IUPAC Name: 5-fluoro-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H10F2N2O5/c10-3-1-13(9(17)12-7(3)16)8-5(11)6(15)4(2-14)18-8/h1,4-6,8,14-15H,2H2,(H,12,16,17)/t4-,5+,6-,8-/m1/s1
Synonyms: 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-fluoro-2,4(1H,3H)-pyrimidinedione; FF-Ara-ura; 5-Fluoro-1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-(2-Fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-fluorouracil

2'-Deoxy-2'-fluoro-5-methyl-beta-D-arabinouridine

Description: 2'-Deoxy-2'-fluoro-5-methyl-beta-D-arabinouridine is a chemically modified nucleoside used in biochemical research and oligonucleotide synthesis. It can be used in various research settings to study RNA and DNA interactions, enzymatic processes involving modified nucleosides, and the effects of nucleotide modifications on nucleic acid structure and function.
CAT: BRP-02032
CAS: 69256-17-3
MF: C10H13FN2O5
MF: 260.22
Purity: ≥95%
Appearance: White to Off-white Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20°C
Density: 1.55±0.1 g/cm3 (Predicted)
InChIKey: GBBJCSTXCAQSSJ-JVZYCSMKSA-N
CanonicalSMILES: CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F
IUPAC Name: 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
InChI: InChI=1S/C10H13FN2O5/c1-4-2-13(10(17)12-8(4)16)9-6(11)7(15)5(3-14)18-9/h2,5-7,9,14-15H,3H2,1H3,(H,12,16,17)/t5-,6+,7-,9-/m1/s1
Synonyms: FMAU; 2'-Fluoro-5-methylarabinosyluracil; 2'-FANA-Tr; 2'-Deoxy-2'-fluoro-arabino-thymidine; Clevudine; 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione; 1-(2'-Deoxy-2'-fluoro-β-D-arabinofuranosyl)-5-methyluracil; 2'-Fluoro-5-methyl-1-β-D-arabinofuranosyluracil; 5-Methyl-2'-fluoroarauracil; D-FMAU

3′-Deoxy-3′-fluoroguanosine

Description: 3'-Deoxy-3'-fluoroguanosine, an antiviral agent, is a modified nucleoside used in biochemical research and therapeutic development to enhance the stability and binding properties of oligonucleotides. The removal of the 3' hydroxyl group (deoxy) and substitution with a fluorine atom at the 3' position increase resistance to enzymatic degradation and improve the molecule's overall stability, making it useful in the development of stable therapeutic agents and the study of nucleic acid interactions.
CAT: BRP-02034
CAS: 123402-21-1
MF: C10H12FN5O4
MF: 285.23
Purity: ≥95%
Appearance: Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: 4°C, protect from light
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Density: 2.17±0.1 g/cm3 (Predicted)
Melting Point: 289-291°C
Boiling Point: 726.1±70.0°C at 760 mmHg
InChIKey: VDOWHLFGBWKXJC-DXTOWSMRSA-N
CanonicalSMILES: NC(NC1=O)=NC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](F)[C@H]3O
IUPAC Name: 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C10H12FN5O4/c11-4-3(1-17)20-9(6(4)18)16-2-13-5-7(16)14-10(12)15-8(5)19/h2-4,6,9,17-18H,1H2,(H3,12,14,15,19)/t3-,4-,6-,9-/m1/s1
Synonyms: 123402-21-1;3'-Deoxy-3'-fluoroguanosine;2-Amino-9-((2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one;Guanosine, 3'-deoxy-3'-fluoro-;3fluoro-3deoxyguanosine;3-Deoxy-3-fluoroguanosine;CHEMBL420751;2-AMINO-9-[(2R,3S,4S,5R)-4-FLUORO-3-HYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1H-PURIN-6-ONE;2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one;3'-fluoro-3'-deoxyguanosine;SCHEMBL1737325;3??-Deoxy-3??-fluoroguanosine;DTXSID10154008;BDBM50144938;MFCD09263707;AKOS022180601;2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one;AC-32289;AS-60089;F12908;A805067;9-[3-Deoxy-3-C-fluoro-beta-D-rbiofuranosyl]guanine;2-Amino-9-((2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one;2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-6-one;2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one;

3'-Deoxy-3'-fluoroadenosine

Description: 3'-Deoxy-3'-fluoroadenosine, an extensively utilized potent antiviral agent within the biomedical sector, demonstrates paramount significance in combating viral infections, primarily instigated by RNA viruses. Its exceptional configuration facilitates a profound affinity towards viral polymerases, thereby impeding their functionality and thwarting viral replication. This compound's expansive range of antiviral efficacy endows it with utmost utility in the relentless battle against an array of viral maladies.
CAT: BRP-02036
CAS: 75059-22-2
MF: C10H12FN5O3
MF: 269.23
Purity: ≥95%
Appearance: White to Pale Yellow to Brown Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
Density: 2.01±0.1 g/cm3 (Predicted)
Melting Point: 211-212 °C
Boiling Point: 628.6±65.0 °C at 760 mmHg
InChIKey: QCDAWXDDXYQEJJ-QYYRPYCUSA-N
CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)F)O)N
IUPAC Name: (2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-4-fluoro-5-(hydroxymethyl)oxolan-3-ol
InChI: InChI=1S/C10H12FN5O3/c11-5-4(1-17)19-10(7(5)18)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1H2,(H2,12,13,14)/t4-,5-,7-,10-/m1/s1
Synonyms: Adenosine, 3-deoxy-3-fluoro-; 3'-Fluoro-3'-deoxyadenosine; (2R,3S,4S,5R)-2-(6-amino-9H-purin-9-yl)-4-fluoro-5-(hydroxymethyl)tetrahydrofuran-3-ol; 3'-F-dA

(2'R)-2'-Deoxy-2'-fluoro-2'-Methyl-uridine 3',5'-dibenzoate

Description: (2'R)-2'-Deoxy-2'-fluoro-2'-Methyl-uridine 3',5'-dibenzoate, a remarkable therapeutic agent, demonstrates potential in the fight against cancer, prohibiting tumor growth and prompting apoptosis in cancer cells.
CAT: BRP-02040
CAS: 863329-65-1
MF: C24H21FN2O7
MF: 468.43
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C
Density: 1.42±0.1 g/cm3
Melting Point: 256-258 °C
InChIKey: OUDQYAYIRAUNLO-PDKZGUECSA-N
CanonicalSMILES: CC1(C(C(OC1N2C=CC(=O)NC2=O)COC(=O)C3=CC=CC=C3)OC(=O)C4=CC=CC=C4)F
IUPAC Name: [(2R,3R,4R,5R)-3-benzoyloxy-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-4-methyloxolan-2-yl]methyl benzoate
InChI: InChI=1S/C24H21FN2O7/c1-24(25)19(34-21(30)16-10-6-3-7-11-16)17(14-32-20(29)15-8-4-2-5-9-15)33-22(24)27-13-12-18(28)26-23(27)31/h2-13,17,19,22H,14H2,1H3,(H,26,28,31)/t17-,19-,22-,24-/m1/s1
Synonyms: ((2R,3R,4R,5R)-3-(Benzoyloxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate; Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, 3',5'-dibenzoate, (2'R)-; [(2R,3R,4R,5R)-3-Benzoyloxy-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-4-methyl-tetrahydrofuran-2-yl]methyl benzoate; (2R,3R,4R,5R)-2-[(benzoyloxy)methyl]-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-4-fluoro-4-methyloxolan-3-yl benzoate

9-(2-Deoxy-2-fluoro-b-D-xylofuranosyl)-9H-purin-6-amine

Description: 9-(2-Deoxy-2-fluoro-b-D-xylofuranosyl)-9H-purin-6-amine, commonly known as DFXY, is a remarkable antiviral agent employed for combatting specific viral infections, including hepatitis B and C. With its precise mechanism of action targeting the viral polymerase enzyme, DFXY displays remarkable effectiveness in hindering viral replication.
CAT: BRP-02041
CAS: 123334-75-8
MF: C10H12FN5O3
MF: 269.23
Purity: ≥97% by HPLC
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 2.01±0.1 g/cm3
Boiling Point: 628.6±65.0 °C at 760 mmHg
InChIKey: ZGYYPTJWJBEXBC-XEVJOGTHSA-N
CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)F)N
IUPAC Name: (2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
InChI: InChI=1S/C10H12FN5O3/c11-5-7(18)4(1-17)19-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1H2,(H2,12,13,14)/t4-,5-,7+,10-/m1/s1
Synonyms: (2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol; 9H-Purin-6-amine, 9-(2-deoxy-2-fluoro-β-D-xylofuranosyl)-; 9-(2-Deoxy-2-fluoro-β-D-xylofuranosyl)-9H-purin-6-amine; 2'-Fluoro-2'-deoxy-β-D-xylo-adenosine
* Only for research. Not suitable for any diagnostic or therapeutic use.
Inquiry Basket